Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Chiara Ditto

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Biology|November 27, 2021
Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus InfectionMarta Priora, Richard Borrelli, Simone Parisi, et al.
Clinical and Experimental Rheumatology|September 17, 2020
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapyMaria Chiara Ditto, Simone Parisi, Valentina Varisco, et al.
Rheumatology (Oxford, England)|April 3, 2014
Standard and pocket-size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patientsChiara Cogliati, Marco Antivalle, Daniela Torzillo, et al.
Disease Markers|September 16, 2017
Measurement of Serum Klotho in Systemic SclerosisRossella Talotta, Sara Bongiovanni, Teresa Letizia, et al.
Journal of Clinical Medicine|January 23, 2024
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric StudyCaterina Baldi, Simone Parisi, Paolo Falsetti, et al.
Rheumatology and Immunology Research|December 5, 2022
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT StudyNicoletta Luciano, Enrico Fusaro, Maria Chiara Ditto, et al.
RMD Open|September 7, 2021
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritisMaria Chiara Ditto, Simone Parisi, Gianpiero Landolfi, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Journal of Personalized Medicine|March 25, 2022
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective AnalysisAndrea Becciolini, Simone Parisi, Rosalba Caccavale, et al.
Journal of Clinical Medicine|February 15, 2022
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term StudySimone Parisi, Andrea Becciolini, Maria Chiara Ditto, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biology|November 27, 2021
Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus InfectionMarta Priora, Richard Borrelli, Simone Parisi, et al.
Clinical and Experimental Rheumatology|September 17, 2020
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapyMaria Chiara Ditto, Simone Parisi, Valentina Varisco, et al.
Rheumatology (Oxford, England)|April 3, 2014
Standard and pocket-size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patientsChiara Cogliati, Marco Antivalle, Daniela Torzillo, et al.
Disease Markers|September 16, 2017
Measurement of Serum Klotho in Systemic SclerosisRossella Talotta, Sara Bongiovanni, Teresa Letizia, et al.
Journal of Clinical Medicine|January 23, 2024
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric StudyCaterina Baldi, Simone Parisi, Paolo Falsetti, et al.
Rheumatology and Immunology Research|December 5, 2022
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT StudyNicoletta Luciano, Enrico Fusaro, Maria Chiara Ditto, et al.
RMD Open|September 7, 2021
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritisMaria Chiara Ditto, Simone Parisi, Gianpiero Landolfi, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Journal of Personalized Medicine|March 25, 2022
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective AnalysisAndrea Becciolini, Simone Parisi, Rosalba Caccavale, et al.
Journal of Clinical Medicine|February 15, 2022
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term StudySimone Parisi, Andrea Becciolini, Maria Chiara Ditto, et al.
Pageof 5